About this trial
Poor sleep affects over half of U.S. cancer survivors, contributing to daytime fatigue, reduced physical activity, and diminished quality of life. Traditional sleep treatments often target diagnosed disorders, leaving many survivors with subclinical sleep issues underserved. Sleep health-a broader concept encompassing sleep regularity, satisfaction, alertness, timing, efficiency, and duration (RU-SATED)-offers a more inclusive framework for intervention. The TSHI is a modular, skills-based program designed to improve these dimensions of sleep health. Delivered via six weekly one-on-one Zoom sessions, TSHI emphasizes behavioral strategies like sleep hygiene, relaxation, and energy management.
This six-week, single-group quasi-experimental pilot study will enroll 10 cancer survivors to assess the feasibility, acceptability, and preliminary effectiveness of TSHI. Researchers will evaluate changes in sleep health, fatigue, physical activity, and quality of life using surveys, interviews, and ActiGraph data. By targeting sleep as a modifiable health behavior, this study aims to lay the groundwork for scalable interventions that enhance recovery and well-being in cancer survivors.
Eligibility criteria
Qualifiers
≥18 years old
≤7 on RU-SATED questionnaire
≥6 months removed from primary cancer treatment
able to speak/read English
Disqualifiers
≥15 on Patent Health Questionnaire 8
≥10 on Generalized Anxiety Disorder-7
self-reported current or recent history (≤2 years) of drug or alcohol abuse
history of nervous system disorder [e.g., stroke, Parkinson's disease, multiple sclerosis]
Trial design
Treatments tested in this trial
- Transdiagnostic Sleep Health Intervention (TSHI)